Recent guidance emphasizes the critical importance of verifying the licensure of wholesale drug distributors and third-party logistics providers in the United States. The FDA has reiterated that prescription drugs should only be procured from licensed entities, underscoring the need for compliance in the pharmaceutical supply chain. This directive is particularly relevant in light of ongoing concerns regarding drug integrity and safety, which have been exacerbated by the complexities of global sourcing and distribution.
In this context, the responsibility falls on pharmaceutical professionals, particularly those in regulatory, quality assurance, and supply chain roles, to ensure that their procurement processes adhere to these standards. Failure to verify licensure not only poses a risk to patient safety but can also lead to significant regulatory repercussions for companies. As the landscape of drug distribution continues to evolve, maintaining vigilance over supplier credentials is paramount for safeguarding the integrity of the pharmaceutical supply chain.
Use the database as your supply chain compass →
